Q1 FY27 results: Revenue steady, PAT jumps 83% YoY on consolidated basis

Pat Growth 25pctExceptional ItemResults View source PDF Explain this filing

RHIM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.2%Reaction day

₹415.20

prior close

₹420.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-0.3%-6.9% vs market

Electrodes & Refractories peers, median of 10sector-0.7%-6.4% vs sector

On the reaction day the stock moved 6.9 pts less than Nifty Smallcap 250 and 6.4 pts less than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-5.1

10m

-4.4

15m

-4.9

30m

-5.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.2-0.3-6.9-0.7-6.4

Next day

-5.7-0.1-5.6+0.2-5.9

-8.2-0.6-7.7+1.3-9.6

-10.0-0.4-9.7+0.4-10.4

-8.4-0.2-8.2+1.0-9.3

-9.7-0.8-8.9-0.1-9.6

-9.7+0.2-9.9-1.2-8.5

15d

-10.7-0.7-10.1-2.2-8.5

-12.9-2.7-10.2-6.9-6.0

-11.2-3.3-7.9-4.3-6.8

—————

UpDownMarket · Nifty Smallcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RHI Magnesita India posted Q1 FY27 results. Consolidated revenue grew 5.6% YoY to Rs. 1,013.97 crore while PAT surged 83% to Rs. 64.6 crore from Rs. 35.3 crore. Standalone revenue was flat at Rs. 803.45 crore, but PAT rose 68% to Rs. 78.2 crore. EPS stood at Rs. 3.13 (consolidated) and Rs. 3.79 (standalone). Prior quarter had a Rs. 556.24 crore goodwill impairment. Auditor Price Waterhouse issued clean review reports.

Likely market impact

Strong profit growth driven by lower costs despite flat revenue. New JV with Khemka for mineral processing. Clean audit, no fresh impairments. Positive for shareholders.